A next-generation CAR T cell immunotherapy targeting the urokinase receptor has eliminated treatment-resistant glioblastoma tumours in preclinical models.
University of California, San Francisco researchers have identified a crucial immune mechanism involving CD4+ T cells that ...
University of Pennsylvania researchers have developed ApexGO, an AI system that refines imperfect antibiotic candidates ...
A novel compound developed over 15 years of research has demonstrated unprecedented activity against liver, blood and sexual ...
German researchers have developed genESOM, a generative AI system that could reduce animal numbers in preclinical drug ...
A molecular switch that activates an alternative energy-burning pathway in brown fat has been identified by McGill University ...
In drug discovery, a failed sample run is not just a setback - it can mean months of lost work and significant cost. At ...
Dr Gary Kusdian is a molecular biologist with a PhD from Heinrich Heine University Düsseldorf, specialising in ...
A preclinical study from Osaka Metropolitan University demonstrates that levofloxacin and cefiderocol both show therapeutic ...
The American Society of Gene & Cell Therapy's 2026 Annual Meeting opens in Boston on 11 May, bringing together thousands of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results